Interpretation of 2022 IPNA clinical practice recommendation for the diagnosis and management in children with steroid-sensitive nephrotic syndrome and comparison with 2016 guideline of China

VernacularTitle:2022年国际儿科肾脏病学会儿童激素敏感型肾病综合征的诊断和管理临床实践指南解读及与2016年国内指南比较
Author: Pei ZHANG ¹ ; Chunlin GAO ; Jun YAO ; Zhengkun XIA
Author Information

1. 南京大学医学院附属金陵医院（东部战区总医院）儿科，南京　210002
Keywords: Nephrotic syndrome; Glucocorticoids; Child; Diagnostic and treatment guideline; Interpretation
From: Chinese Journal of Nephrology 2023;39(11):872-878
CountryChina
Language:Chinese
Abstract: Relapsing is the clinical characteristic of nephrotic syndrome (NS) in children, and some steroid-sensitive NS (SSNS) children have frequently relapsing NS and steroid-dependent NS. The long-term and frequent uses of glucocorticoids, as well as the adverse effects of immunosuppressants, seriously affect the quality of life in children with NS. The International Pediatric Nephrology Association released the clinical practice recommendation for SSNS in children in 2022. Based on the guideline for the diagnosis and treatment of steroid-sensitive, frequently- relapsing/dependent NS in children (2016) formulated by the Nephrology Group of Pediatrics Society of Chinese Medical Association, we interpreted the guideline on clinical treatment and management suggestions of SSNS, to provide references for the diagnosis and treatment of SSNS in children.